Latest News

Featured News

Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody^{^®} iSCIB1+

Jul 22, 2025

First patient dosed in the expansion phase of the monotherapy arms of ModiFY

October 31, 2022

Preliminary Results for the year ended 30 April 2022

October 28, 2022

Scancell signs Commercial License Agreement with Genmab

October 25, 2022

Scancell Change of Registered Office

September 6, 2022

First patient dosed in Cohort 2 of the ModiFY Phase 1 clinical trial

August 16, 2022

Scancell to produce and clinically validate T cell redirecting bispecific antibodies

June 23, 2022

4
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
5

No results found.

Regulatory News Archive

JOIN OUR MAILING LIST

Sign up for news updates to stay up to date with Scancell.